Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec:3:41-47.
doi: 10.1016/j.rbms.2017.01.001.

Comparative preimplantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism

Michelle J Bayefsky  1
Affiliations

Comparative preimplantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism

Michelle J Bayefsky. Reprod Biomed Soc Online. 2016 Dec.

Abstract

Unlike many European nations, the USA has no regulations concerning the use of preimplantation genetic diagnosis (PGD), a technique employed during some fertility treatments to select embryos based on their genes. As such, PGD can and is used for a variety of controversial purposes, including sex selection, selection for children with disabilities such as deafness, and selection for 'saviour siblings' who can serve as tissue donors for sick relatives. The lack of regulation, which is due to particular features of the US political and economic landscape, has ethical and practical implications for patients seeking PGD around the world. This paper contrasts the absence of PGD oversight in the USA with existing PGD policies in Switzerland, Italy, France and the UK. The primary reasons why PGD is not regulated in the USA are addressed, with consideration of factors such as funding for assisted reproductive technology treatmemt and the proximity of PGD to the contentious abortion debate. The obstacles that would need to be overcome in the USA for PGD to be regulated in the future are outlined. Then, the significance of the current divergence in PGD policy for patients around the world are discussed. Regulatory differences create opportunities for reproductive tourism, which result in legal, health and moral challenges. The paper concludes with comments on the need for policymakers around the world to balance respect for the characters and constitutions of their individual countries with appreciation of the needs of infertile patients across the globe.

Keywords: comparative policy; embryo; preimplantation genetic diagnosis; reproductive tourism; selection.

PubMed Disclaimer

Conflict of interest statement

Declaration: The author reports no financial or commercial conflicts of interest. The opinions expressed herein are the author’s and do not reflect the policies and positions of the National Institutes of Health, the US Public Health Service or the US Department of Health and Human Services.

References

    1. Baruch S., Kaufman D., Hudson K. Genetic Testing of Embryos: Practices and Perspectives of US In Vitro Fertilization Clinics. Fertil. Steril. 2008;89(5):1053–1058. - PubMed
    1. Bayefsky M. The Regulatory Gap for Preimplantation Genetic Diagnosis. Hast. Cent. Rep. 2015;45(1):7–8. - PubMed
    1. Bayefsky M., Jennings B. Palgrave Macmillan; New York: 2015. Regulating Preimplantation Genetic Diagnosis in the United States: The Limits of Unlimited Selection.
    1. Biondi S. Access to Medical-Assisted Reproduction and PGD in Italian Law: A Deadly Blow to an Illiberal Statute? Commentary to the European Court on Human Rights’ Decision Costa and Pavan V Italy (ECtHR, 28 August 2012, App. 54270/2010) Med. Law Rev. 2013;21(3):474–486. - PubMed
    1. Committee on Ethics of the American Congress of Obstetricians and Gynecologists . 2007. Sex Selection. Number 360.

LinkOut - more resources